ALC
KIDS icon

Alexander Labrunerie & Co’s OrthoPediatrics KIDS Stock Holding History

Alexander Labrunerie & Co’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,176
Closed -$249K – 106
2024
Q3 		$249K Hold
9,176
– – 0.11% 85
2024
Q2 		$264K Hold
9,176
– – 0.14% 74
2024
Q1 		$268K Buy
+9,176
New +$257K 0.15% 71

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alexander Labrunerie & Co's KIDS Position: Q4 2024 in Review

Alexander Labrunerie & Co sold out of OrthoPediatrics (KIDS) in Q4 2024, closing a stake of 9,176 shares — an estimated $249K sold.

Alexander Labrunerie & Co first reported a position in KIDS in Q1 2024 and held it in 3 quarters. The position peaked at $268K in Q1 2024. 108 funds tracked by Wall St. Rank hold KIDS as of Q4 2024.

  • Alexander Labrunerie & Co reported no remaining OrthoPediatrics position as of Q4 2024 after selling out during the quarter.
  • Alexander Labrunerie & Co sold 9,176 OrthoPediatrics shares in Q4 2024, an estimated $249K.
  • Alexander Labrunerie & Co first reported a position in OrthoPediatrics in Q1 2024 and held it in 3 quarters.
  • Alexander Labrunerie & Co's OrthoPediatrics position peaked at $268K in Q1 2024.
  • 108 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2024.

Based on Alexander Labrunerie & Co's 13F filing for Q4 2024, filed 27 Jan 2025.